Yes. Aldevron and IDT are two companies (owned by danaher) that collaborated to make this happen. They have multiple authors listed in the NEJM article.
https://jobs.danaher.com/global/en/search-results?keywords=S...
Mark Behlke's group at IDT is the force behind a LOT of the development of CRISPR, but they are relatively unknown